Antibiotic Policies: Fighting Resistance

1. Consequences of Antimicrobial Chemotherapy: Overgrowth, Resistance, and Virulence
Stephanie J. Dancer

2. The Process of Antibiotic Prescribing: Can It Be Changed?
Jos W.M. van der Meer, Richard P.T.M. Grol

3. Cultural and Socioeconomic Determinants of Antibiotic Use
Stephan Harbarth, Dominique L. Monnet

4. Electronic Prescribing
Mical Paul, Roberto Cauda, Leonard Leibovici

5. Prevalence Surveys of Antimicrobial Use in Hospitals: Purpose, Practicalities, and Pitfalls
R. Andrew Seaton

6. Antibiotic Use in Hospitals in the United States SCOPE-MMIT Antimicrobial Surveillance Network
Amy Pakyz, Ron Polk

7. New Hospital Initiatives in Fighting Resistance
Fiona Cooke, Alison Holmes

8. Antimicrobial Resistance: Preventable or Inevitable?
Duygu Yazgan Aksoy, Mine Durusu Tanriover, Serhat Unal

9. Fighting Antimicrobial Resistance in the Mediterranean Region
Michael A. Borg

10. Cystic Fibrosis—Coping with Resistance
Oana Ciofu, Niels Høiby

11. Community-Acquired Pneumonia—Back to Basics
Marc J.M. Bonten, Jan Jelrik Oosterheert

12. Hospital-Acquired Pneumonia: Diagnostic and Treatment Options
Marìa V. Torres, Patricia Mu?oz, Emilio Bouza

13. Optimizing Antimicrobial Chemotherapy in the ICU—A Review
Ian G. Gould

14. Risk Assessment for Methicillin-Resistant Staphylococcus aureus
Evelind Tacconelli

15. What Do We Do with Methicillin-Resistant Staphylococcus aureus in Surgery?
Giorgio Zanetti

16. Control of Healthcare-Associated Methicillin-ResistantStaphylococcus aureus
Jan A.J.W. Kluytmans, Bram M.W. Diederen

DRM-restrictions

Printing: not available
Clipboard copying: not available

Avainsanat: TECHNOLOGY & ENGINEERING / Biomedical TEC059000